To further examine the involvement of the PD-L1/PD-1 axis in dengue disease severity, we evaluated whether blocking PD-L1/PD-1 interactions with a PD-1 monoclonal antibody (mAb) influences severe disease outcome (Fig. 7B–G). This evidence concerns the gene CD274 and dengue disease.